Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Branded Generics Market by Product (Trade Named Generics, Value-Added), Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 494.29 billion in 2024, at a CAGR 14.66% to reach USD 1,126.43 billion by 2030. Branded generic drugs refer to medications that are bioequivalent to the original ... Read More
-
Disodium Inosinate Market by Grade (Food Grade, Pharmaceutical Grade), Source (Animal Source, Plant Source), Application - Global Forecast 2024-2030
... reach USD 816.23 million in 2024, at a CAGR 6.48% to reach USD 1,193.34 million by 2030. The disodium inosinate (C10H11N4Na2O8P) is derived from fish, including flesh and the disodium salt of inosinic acid, which ... Read More
-
Sodium Chloride Market by Type (Rock Salt, Solar Salt, Vacuum Salt), Grade (Food Grade, Lab Grade, Pharmaceutical Grade), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 23.69 billion in 2024, at a CAGR 4.80% to reach USD 31.43 billion by 2030. Sodium chloride, commonly known as salt, occurs from a chemical reaction between sodium and ... Read More
-
2024 Global: Medicaments Of Alkaloids Or Derivatives Thereof, N.P.R.S. Products-Manufacturing Forecast (2030) report
... data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
2024 Global: Medicaments Containing Hormones But Not Antibiotics, For Therapeutic Or Prophylactic Uses, Not Put Up In Measured Doses Or For Retail Sale (Excluding Insulin) Products-Manufacturing Forecast (2030) report
... But Not Antibiotics, For Therapeutic Or Prophylactic Uses, Not Put Up In Measured Doses Or For Retail Sale (Excluding Insulin) Products-Manufacturing Forecast (2030) report analyzies the market size, projected growth/decline and regional data for the ... Read More
-
Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030
... USD 620.68 billion in 2023 and expected to reach USD 672.44 billion in 2024, at a CAGR 8.66% to reach USD 1,110.17 billion by 2030. Pharmaceutical manufacturing comprises research, development, production, marketing, and distribution of ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Botanicals Market by Source (Bark, Flowers, Leaves), Extracted Form (Liquid, Powder), Application, Distribution Channel - Global Forecast 2024-2030
... 49.40 billion in 2024, at a CAGR 7.35% to reach USD 76.05 billion by 2030. A botanical is a plant or part of a plant that is used worldwide due to its therapeutic properties, flavor, ... Read More
-
Tert-butanol Market by Product Type (Chemical Grade, Pharmaceutical Grade), End-User (Flavors & Fragrance, Paints & Coatings, Pharmaceuticals), Application - Global Forecast 2024-2030
... expected to reach USD 692.83 million in 2024, at a CAGR 5.47% to reach USD 954.87 million by 2030. Tert-butanol, or 2-methyl-2-propanol (IUPAC name), is a chemical compound with the formula C4H10O. Tert-butanol is a ... Read More
-
Dermatology Drugs Market by Therapeutic Class (Antifungals, Corticosteroids, Immunosuppressants), Route of Administration (Oral, Parenteral Injection, Topical), Indication Type, End-User, Distribution Channel - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 34.23 billion in 2024, at a CAGR 9.83% to reach USD 60.56 billion by 2030. Dermatology drugs encompass a wide array of pharmaceutical compounds specifically developed and ... Read More
-
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030. The pharmaceutical market, comprising the discovery, development, production, and distribution of a ... Read More
-
Botanical Supplements Market by Source (Flower, Fruits, Leaves), Age-Group (0-10 Years, 11-20 Years, 21-45 Years), Form, Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.16 billion in 2024, at a CAGR 15.69% to reach USD 118.61 billion by 2030. Botanical supplements are nutritional supplements made from plants or plant extracts and are often ... Read More
-
Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 29.18% to reach USD 97.35 billion by 2030. Artificial intelligence (AI) in the pharmaceutical market refers to integrating advanced machine ... Read More
-
Scopolamine Market - By Dosage Form (Transdermal Patches, Tablets, Injectables), Application (Motion Sickness, Postoperative Nausea and Vomiting), Route of Administration (Topical, Oral, Parenteral), Distribution Channel – Global Forecast (2024 – 2032)
... witness 5.3% CAGR between 2024 and 2032, fueled by increasing collaborative research in the field. Scopolamine, an anticholinergic drug used primarily for its antiemetic and anticholinergic properties, is seeing heightened interest due to its potential ... Read More
-
Latin America Pharmaceutical Logistics Market: Forecast Analysis 2024-2032
... industry in Latin America is notably fragmented, comprising numerous small companies. Identifying a reliable distributor remains a significant challenge for pharmaceutical firms, necessitating a meticulous screening process. Despite these challenges, the region’s robust industry makes ... Read More
-
Global Pharmaceutical Logistics Market: Forecast Analysis 2024-2032
... market size was $94856.53 million in 2023 and is expected to reach a revenue of $185139.34 million by 2032. PHARMACEUTICAL LOGISTICS MARKET ANALYSIS The pharmaceutical logistics industry has witnessed significant growth due to increasing demand ... Read More
-
Asia-Pacific Pharmaceutical Logistics Market: Forecast Analysis 2024-2032
... by its significant aging population and rising prevalence of chronic diseases, is witnessing substantial growth in its pharmaceutical logistics market. This growth is fueled by increased healthcare spending and government investments in R&D, particularly in ... Read More
-
Pharmaceutical Packaging Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Pharmaceutical Packaging Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Pharmaceutical Packaging Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
North America Pharmaceutical Logistics Market: Forecast Analysis 2024-2032
... The growth in pharmaceutical sales is a primary driver of the pharmaceutical logistics market in North America. Additionally, the rising geriatric population in the region has led to an increase in chronic diseases, spurring demand ... Read More
-
Middle East And Africa Pharmaceutical Logistics Market: Forecast Analysis 2024-2032
... forecasted period 2024-2032. The rising awareness about healthcare and increasing per capita income have significantly boosted the demand for healthcare services. The rapid population growth has further fueled the need for pharmaceuticals, attracting multinational pharmaceutical ... Read More
-
Global Pharmaceutical Processing Equipment Market
... of 2024 to 2031. Market Segmentation Global Pharmaceutical Processing Equipment Market, By Equipment (Mixers, Blenders, Granulators, Pumps, Heat Exchanges, and Others), Dosage Type (Solid Dosage Processing Equipment, Liquid Dosage Processing Equipment, and Semi-Solid Dosage Equipment), ... Read More
-
Moderate to Severe Atopic Dermatitis (AD) – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Moderate to Severe Atopic Dermatitis (AD), historical and forecasted epidemiology as well as the Moderate to Severe Atopic Dermatitis (AD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Europe Pharmaceutical Processing Equipment Market
... of 2024 to 2031. Market Segmentation Europe Pharmaceutical Processing Equipment Market, By Equipment (Mixers, Blenders, Granulators, Pumps, Heat Exchanges, and Others), Dosage Type (Solid Dosage Processing Equipment, Liquid Dosage Processing Equipment, and Semi-Solid Dosage Equipment), ... Read More